OLANZAPINE TEVA ® 7.5 MG

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

OLANZAPINE 7.5 MG

Dostupné s:

SALOMON,LEVIN & ELSTEIN LTD

ATC kód:

N05AH03

Léková forma:

FILM COATED TABLETS

Podání:

PER OS

Výrobce:

TEVA OPERATIONS POLAND SP.ZO.O

Terapeutické skupiny:

OLANZAPINE

Terapeutické indikace:

Acute and maintenance treatment of schizophrenia. Olanzapine Teva® is indicated for the management of the manifestations of psychotic disorders. Olanzapine Teva® is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.Prevention of recurrence in Bipolar Disorder: In patients whose manic episode has responded to olanzapine treatment Olanzapine Teva® is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder. The combination of Olanzapine Teva® with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Datum autorizace:

2011-04-01